CR Double-Crane Pharmaceutical's Unit Gets Nod to Market Schizophrenia Drug
CR Double-Crane Pharmaceutical's Unit Gets Nod to Market Schizophrenia Drug
CR DoubleCrane Pharmaceutical旗下部门获准上市精神分裂症药物
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册